Lexon must pay £1.2m as CMA nortriptyline probe upheld
The Competition Appeal Tribunal (CAT) has dismissed Lexon (UK)’s appeal of a CMA fine and investigation, which said the company broke the law over the supply of nortriptyline.
The Competition Appeal Tribunal (CAT) has dismissed Lexon (UK)’s appeal of a CMA fine and investigation, which said the company broke the law over the supply of nortriptyline.